Encorafenib plus cetuximab with or without binimetinib for BRAFV600E metastatic colorectal cancer (mCRC): Relationship between carcinoembryonic antigen (CEA) and clinical outcomes from BEACON CRC Meeting Abstract
| Authors: | Grothey, A.; Kopetz, S.; Yaeger, R.; Van Cutsem, E.; Wasan, H.; Desai, J.; Ciardiello, F.; Yoshino, T.; Maharry, K.; Christy-Bittel, J.; Gollerkeri, A.; Tabernero, J. |
| Abstract Title: | Encorafenib plus cetuximab with or without binimetinib for BRAFV600E metastatic colorectal cancer (mCRC): Relationship between carcinoembryonic antigen (CEA) and clinical outcomes from BEACON CRC |
| Meeting Title: | ESMO 22nd World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Jul 1-4 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-07-01 |
| Start Page: | S243 |
| Language: | English |
| ACCESSION: | WOS:000558722000452 |
| DOI: | 10.1016/j.annonc.2020.04.484 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA-7 -- Source: Wos |
